Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HENRY RODRIGUEZ

Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology

NPI
1962434662
CMS profile
179371
Location
TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$78,819.50

50 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
SANOFI-AVENTIS U.S. LLC $77,476.22 47
Merck Sharp & Dohme LLC $1,162.50 1
Ascendis Pharma Inc $96.64 1
Dexcom, Inc. $84.14 1

Page 1 of 1; records 1–50 of 50 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HENRY RODRIGUEZ

NPI 1962434662 · CMS profile ID 179371

Allopathic & Osteopathic Physicians / Pediatrics / Pediatric Endocrinology

TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–50 of 50 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1962434662?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HENRY RODRIGUEZ, NPI 1962434662, CMS profile ID 179371. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–50 of 50 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1962434662?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). HENRY RODRIGUEZ, NPI 1962434662, CMS profile ID 179371. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–50 of 50 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1962434662?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
HENRY RODRIGUEZ, NPI 1962434662, CMS profile ID 179371, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–50 of 50 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1962434662?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

50 matching records · $78,819.50 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 50 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 50.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
SANOFI-AVENTIS U.S. LLC $2,258.0012/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991655 CMS
SANOFI-AVENTIS U.S. LLC $3,548.0012/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991671 CMS
SANOFI-AVENTIS U.S. LLC $45.5712/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991673 CMS
SANOFI-AVENTIS U.S. LLC $56.5111/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991595 CMS
SANOFI-AVENTIS U.S. LLC $1,032.3111/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991641 CMS
SANOFI-AVENTIS U.S. LLC $294.9011/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991643 CMS
SANOFI-AVENTIS U.S. LLC $8,063.0011/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991645 CMS
SANOFI-AVENTIS U.S. LLC $28.0010/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991579 CMS
SANOFI-AVENTIS U.S. LLC $25.8110/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991581 CMS
SANOFI-AVENTIS U.S. LLC $890.3010/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991583 CMS
SANOFI-AVENTIS U.S. LLC $809.1610/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991585 CMS
SANOFI-AVENTIS U.S. LLC $8,063.0010/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991587 CMS
SANOFI-AVENTIS U.S. LLC $25.8610/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991589 CMS
SANOFI-AVENTIS U.S. LLC $17.2610/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991651 CMS
SANOFI-AVENTIS U.S. LLC $3,548.0010/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991647 CMS
SANOFI-AVENTIS U.S. LLC $32.0610/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991649 CMS
Ascendis Pharma Inc $96.6408/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133847257 CMS
SANOFI-AVENTIS U.S. LLC $7.0908/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991657 CMS
SANOFI-AVENTIS U.S. LLC $24.0008/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991659 CMS
SANOFI-AVENTIS U.S. LLC $91.1008/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991661 CMS
SANOFI-AVENTIS U.S. LLC $420.3908/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991663 CMS
SANOFI-AVENTIS U.S. LLC $652.9108/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991665 CMS
SANOFI-AVENTIS U.S. LLC $8,063.0008/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991667 CMS
SANOFI-AVENTIS U.S. LLC $51.7208/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991669 CMS
SANOFI-AVENTIS U.S. LLC $956.6408/21/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991675 CMS
SANOFI-AVENTIS U.S. LLC $6,773.0008/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991677 CMS
SANOFI-AVENTIS U.S. LLC $125.0008/21/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1155228180 CMS
SANOFI-AVENTIS U.S. LLC $2,258.0007/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991545 CMS
SANOFI-AVENTIS U.S. LLC $4,250.0007/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991577 CMS
SANOFI-AVENTIS U.S. LLC $3,548.0006/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991547 CMS
SANOFI-AVENTIS U.S. LLC $3,548.0006/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991521 CMS
SANOFI-AVENTIS U.S. LLC $127.5006/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991523 CMS
SANOFI-AVENTIS U.S. LLC $20.5006/06/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991525 CMS
Merck Sharp & Dohme LLC $1,162.5006/05/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141778591 CMS
SANOFI-AVENTIS U.S. LLC $37.3205/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991527 CMS
SANOFI-AVENTIS U.S. LLC $3.6505/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991529 CMS
SANOFI-AVENTIS U.S. LLC $17.5005/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991531 CMS
SANOFI-AVENTIS U.S. LLC $559.8005/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991533 CMS
SANOFI-AVENTIS U.S. LLC $271.5805/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991535 CMS
SANOFI-AVENTIS U.S. LLC $6,773.0005/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991537 CMS
SANOFI-AVENTIS U.S. LLC $124.7405/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991539 CMS
SANOFI-AVENTIS U.S. LLC $187.6005/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991541 CMS
SANOFI-AVENTIS U.S. LLC $279.9004/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991505 CMS
SANOFI-AVENTIS U.S. LLC $6,773.0004/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991507 CMS
SANOFI-AVENTIS U.S. LLC $114.6204/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991509 CMS
SANOFI-AVENTIS U.S. LLC $385.9204/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991511 CMS
SANOFI-AVENTIS U.S. LLC $10.0004/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991513 CMS
SANOFI-AVENTIS U.S. LLC $25.0004/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991515 CMS
Dexcom, Inc. $84.1403/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153303699 CMS
SANOFI-AVENTIS U.S. LLC $2,258.0002/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139991501 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,245.98 23
PY2020 $4,037.50 3
PY2021 $10,500.00 5
PY2022 $2,550.00 2
PY2023 $28,773.62 31
PY2024 $78,819.50 50
PY2025 $81,147.34 58

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,132.10 8
PY2025 Principal investigator $23,837.57 17
PY2024 Principal investigator $38,121.96 130
PY2023 Recipient $31,152.69 10
PY2023 Principal investigator $334,432.51 152
PY2022 Principal investigator $280,252.64 210
PY2021 Recipient $106.13 2
PY2021 Principal investigator $321,118.06 433
PY2020 Recipient $2,040.00 1
PY2020 Principal investigator $354,412.20 52
PY2019 Principal investigator $133,599.16 29

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

162 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Mannkind Corporation $2,322.00 12/31/2023 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA
INHALE-1 No dispute reported 06/30/2026 1056253411
Recipient SANOFI US SERVICES INC. $13,601.06 12/14/2023 Covered Recipient Physician A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus No dispute reported 06/30/2026 1035995759
Principal investigator 1 Dexcom, Inc. $964.00 12/05/2023 Non-covered Recipient Entity
University of South Florida Board of Trustees
POST APPROVAL STUDY FOR NON-ADJUNCTIVE USE OF DEXCOM G5 AND G6 CGM SYSTEM FOR DIABETES MANAGEMENT (COACH) No dispute reported 06/30/2026 1060232231
Recipient SANOFI US SERVICES INC. $1,640.00 12/04/2023 Covered Recipient Physician A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus No dispute reported 06/30/2026 1035995729
Recipient SANOFI US SERVICES INC. $2,250.00 12/04/2023 Covered Recipient Physician A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus No dispute reported 06/30/2026 1035995739
Recipient SANOFI US SERVICES INC. $4,500.00 12/04/2023 Covered Recipient Physician A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus No dispute reported 06/30/2026 1035995749
Principal investigator 1 Novo Nordisk AS $399.99 11/22/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009197593
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1006831539
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1006831551
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1006831563
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1006831575
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1006831587
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1006831601
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1006831613
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007181685
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007181697
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007181709
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007181721
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007181733
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007181743
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007181757
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007181769
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007181781
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007181793
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007218975
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007218989
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007219003
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007219017
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007219033
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007219047
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007219063
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007219079
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007219091
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007219105
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007450229
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007450237
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007450249
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007450257
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007450271
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007450279
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007450289
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007528667
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007528682
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007528697
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007528711
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007528723
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007528739
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007528753
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007528771
Principal investigator 1 Novo Nordisk AS $3.57 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007764769
Principal investigator 1 Novo Nordisk AS $3.57 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007764775
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007917405
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007917411
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007917417
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007917423
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007917429
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007917435
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007917441
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007917447
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007917453
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007917461
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007960211
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007960221
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007960233
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007960243
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007960253
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007960263
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007960275
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007960285
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007960295
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007960307
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008016149
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008016165
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008016183
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008016197
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008016211
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008016227
Principal investigator 1 Novo Nordisk AS $6.23 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008016241
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008977535
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008977551
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008977567
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008977585
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008977601
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008977617
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008977635
Principal investigator 1 Novo Nordisk AS $5.50 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008977651
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216215
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216235
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216251
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216267
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216287
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216303
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216319
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216335
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216351
Principal investigator 1 Novo Nordisk AS $5.90 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216367
Principal investigator 1 Novo Nordisk AS $6.23 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216385
Principal investigator 1 Novo Nordisk AS $6.23 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216401
Principal investigator 1 Novo Nordisk AS $6.23 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216417
Principal investigator 1 Novo Nordisk AS $6.23 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216435
Principal investigator 1 Novo Nordisk AS $6.23 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216451
Principal investigator 1 Novo Nordisk AS $6.23 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216467
Principal investigator 1 Novo Nordisk AS $6.23 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216487
Principal investigator 1 Novo Nordisk AS $17.25 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216503
Principal investigator 1 Novo Nordisk AS $27.77 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216519
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216537
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216555
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216571
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216587
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216603
Principal investigator 1 Novo Nordisk AS $36.00 11/13/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009216621
Principal investigator 1 Mannkind Corporation $4,738.50 10/31/2023 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA
INHALE-1 No dispute reported 06/30/2026 1056252657
Principal investigator 1 Novo Nordisk AS $3,339.99 09/22/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007764763
Principal investigator 1 Mannkind Corporation $6,756.75 07/31/2023 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA
INHALE-1 No dispute reported 06/30/2026 1056251835
Principal investigator 1 Novo Nordisk AS $399.99 05/26/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007764755
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $14,571.30 03/20/2023 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 1039707823
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $20,332.30 03/20/2023 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 1039707829
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007347141
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007347151
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007347161
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007347171
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007347183
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007347193
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007347203
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007748149
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007748157
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007748163
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007748169
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007748175
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007748181
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007748187
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007748193
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007748201
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007748207
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1007764749
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008310787
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008310801
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008310815
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008310829
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008310845
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008310859
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008310873
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008310889
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008310903
Principal investigator 1 Novo Nordisk AS $36.00 03/10/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008310917
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $17,190.00 02/22/2023 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 1039707325
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $6,384.01 02/20/2023 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 1039707287
Principal investigator 1 Novo Nordisk AS $1,316.94 01/25/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1008310771
Principal investigator 1 Novo Nordisk AS $2,262.99 01/25/2023 Non-covered Recipient Entity
UNIVERSITY OF S FLORIDA
NN9924-4437 No dispute reported 06/30/2026 1009146911
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $45,932.95 01/23/2023 Non-covered Recipient Entity
University Of South Florida
52 wks Eff. & Saf. Ph III in Paediatrics No dispute reported 06/30/2026 1022142017
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $36,378.90 01/18/2023 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 1039708017
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $37,411.00 01/18/2023 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 1039708083
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $47,650.20 01/18/2023 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 1039708151
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $21,643.50 01/17/2023 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 1039706861
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $26,465.00 01/17/2023 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 1039706928
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $35,339.30 01/17/2023 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 1039706995
Recipient Novo Nordisk AS $313.18 01/09/2023 Covered Recipient Physician NN9924-4437 No dispute reported 06/30/2026 1006623465
Recipient Novo Nordisk AS $175.66 01/09/2023 Covered Recipient Physician NN9924-4437 No dispute reported 06/30/2026 1006623490
Recipient Novo Nordisk AS $68.39 01/09/2023 Covered Recipient Physician NN9924-4437 No dispute reported 06/30/2026 1006623503
Recipient Novo Nordisk AS $108.03 01/09/2023 Covered Recipient Physician NN9924-4437 No dispute reported 06/30/2026 1006623527
Recipient Novo Nordisk AS $79.42 01/09/2023 Covered Recipient Physician NN9924-4437 No dispute reported 06/30/2026 1006623547
Recipient Novo Nordisk AS $8,416.95 01/09/2023 Covered Recipient Physician NN9924-4437 No dispute reported 06/30/2026 1006633637